Postdoctoral scholars are appointed for one year periods and must be re-appointed every year on their anniversary date if they continue in training. The department personnel representative or mentor will notify the OPE that a re-appointment letter should be generated through the OPE during the month prior to the yearly end date. The re-appointment letter will be signed by the Associate Dean of the Office of Postdoctoral Education, the mentor, and the postdoctoral scholar.
If the mentor does not intend to re-appoint the postdoc for another year, the mentor must notify the postdoc in writing three months prior to the re-appointment date. Following the first year of appointment and in subsequent years, if it is apparent that funding will no longer be available or for any other reason, a minimum of three months notice prior to termination must be given to the postdoc in writing by the mentor. The 3 month notice would start from a mutually agreed upon date.
Postdocs in UAB News
Longtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.
Researchers have proposed a model that resolves a seeming paradox in one of the most intriguing areas of the brain, exploring how immature granule cells in the dentate gyrus appear able to enhance pattern separation due to lesser synaptic connectivity than mature cells.
Palliative care helps patients get the most out of life, whether they’re newly diagnosed, a survivor, or nearing the end of their journey. UAB’s palliative care pioneers provide a fresh look at the fast-growing specialty and its emphasis on listening, choices, patient goals, and quality of life.
UAB Research News
AIMTech’s ResistX treadmill will make its debut at the American College of Sports Medicine’s annual conference.
The UAB Cancer Center has received a $29 million National Cancer Institute renewal grant and is re-designated as “comprehensive” with an outstanding rating as a leader in advancing cancer research and care.